20:00 Wed 23 Dec 2020
Redx Pharma plc - Share Purchases by Directors
REDX PHARMA PLC
("Redx" or "the Company")
Share Purchases by Directors
Number of Ordinary shares purchased |
Price per share (pence) |
39,998 |
50p |
Following this,
-Ends-
For further information, please contact:
Redx Pharma Plc |
T: +44 1625 469 918 |
|
|
|
|
SPARK Advisory Partners (Nominated Advisor) |
T: +44 203 368 3550 |
|
|
|
|
WG Partners LLP (Broker) |
T: +44 20 3705 9330 |
Claes Spång/ |
|
|
|
|
|
FTI Consulting |
T: +44 20 3727 1000 |
|
|
About Redx Pharma Plc
Redx is a
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 |
||
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|
a. |
Name |
Lisa Anson |
2 |
Reason for notification |
|
a. |
Position/Status |
Chief Executive |
b. |
Initial notification/ Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a. |
Name |
Redx Pharma Plc |
b. |
LEI |
213800HMS4EBXO589Y37 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a. |
Description of the financial instrument, type of instrument |
Ordinary Shares of 1p each ISIN: GB00BSNB6S51 |
b. |
Nature of the transaction |
Purchase |
c. |
Price(s) and volume(s) |
39,998 at
|
d. |
Aggregated information - Aggregated Volume - Price |
39,998 at 50 pence per share |
e. |
Date of the transaction |
|
f. |
Place of the transaction |
Outside of trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE